Analyst Upgrades – CVS Health (NYSE:CVS) Stock Gets Upgraded By Needham & Company LLC from Buy to Strong-Buy

ME Staff
-
0

Analyst Ratings For CVS Health (NYSE:CVS)

Today, CVS Health (NYSE:CVS) stock received an upgrade by Needham & Company LLC from Buy to Strong-Buy with a price target of $100.00.

Some recent analyst ratings include

  • 1/30/2018-Needham & Company LLC Upgrade from a “Buy ” rating to a ” Strong-Buy” rating.
  • 1/18/2018-Cowen Reiterated Rating of Outperform.
  • 1/5/2018-Morgan Stanley Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
  • 1/4/2018-Raymond James Financial Upgrade from a “Outperform ” rating to a ” Strong-Buy” rating.

Dividend information for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) pays an annual dividend of $2.00 with a yield of 2.53% and an average dividend growth of 22.10% based on a 3 Year Average..

Dividend History for CVS Health (NYSE:CVS)

  • On 12/29/2017 CVS Health announced a quarterly dividend of $0.50 2.72% with an ex dividend date of 1/23/2018 which will be payable on 2/2/2018.
  • On 9/19/2017 CVS Health announced a quarterly dividend of $0.50 2.48% with an ex dividend date of 10/23/2017 which will be payable on 11/3/2017.
  • On 7/6/2017 CVS Health announced a quarterly dividend of $0.50 2.54% with an ex dividend date of 7/20/2017 which will be payable on 8/3/2017.
  • On 3/2/2017 CVS Health announced a quarterly dividend of $0.50 2.47% with an ex dividend date of 4/19/2017 which will be payable on 5/1/2017.
  • On 12/22/2016 CVS Health announced a quarterly dividend of $0.50 2.54% with an ex dividend date of 1/20/2017 which will be payable on 2/2/2017.
  • On 9/22/2016 CVS Health announced a quarterly dividend of $0.43 1.88% with an ex dividend date of 10/20/2016 which will be payable on 11/3/2016.
  • On 7/6/2016 CVS Health announced a quarterly dividend of $0.43 1.78% with an ex dividend date of 7/19/2016 which will be payable on 8/1/2016.

Recent Insider Trading Activity For CVS Health (NYSE:CVS)
CVS Health (NYSE:CVS) has insider ownership of 0.61% and institutional ownership of 81.64%.

  • On 12/21/2017 Lisa Bisaccia, EVP, sold 29,445 with an average share price of $75.00 per share and the total transaction amounting to $2,208,375.00.
  • On 10/2/2017 Thomas M Moriarty, EVP, sold 20,547 with an average share price of $81.17 per share and the total transaction amounting to $1,667,799.99.
  • On 9/18/2017 Jonathan C Roberts, COO, sold 85,743 with an average share price of $83.14 per share and the total transaction amounting to $7,128,673.02.
  • On 9/15/2017 Helena Foulkes, EVP, sold 39,340 with an average share price of $81.88 per share and the total transaction amounting to $3,221,159.20.
  • On 9/13/2017 Larry J Merlo, Insider, sold 241,150 with an average share price of $83.07 per share and the total transaction amounting to $20,032,330.50.
  • On 9/11/2017 David M Denton, CFO, sold 237,078 with an average share price of $79.65 per share and the total transaction amounting to $18,883,262.70.
  • On 9/11/2017 Thomas M Moriarty, EVP, sold 90,267 with an average share price of $79.61 per share and the total transaction amounting to $7,186,155.87.

Recent Trading Activity for CVS Health (NYSE:CVS)
Shares of CVS Health closed the previous trading session at with 78.48999786376953 shares trading hands.